National Eye Institute (NIH)
Overview
The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is to eliminate vision loss and improve quality of life through vision research. NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research. NEI was established in 1968 as the nation's leading supporter of eye health and vision research projects. These projects include basic science research into the fundamental biology of the eye and the visual system. NEI also funds translational and clinical research aimed at developing and testing therapies for eye diseases and disorders.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Universal Adherence LLC | Nov 2025 | Grant | Lead |
| iVeena Delivery Systems | Sep 2025 | Grant | Co-investor |
| RevOpsis Therapeutics | Oct 2024 | Grant | Co-investor |
| BVS Sight, Inc. | Mar 2024 | Grant | Co-investor |
| iVeena Delivery Systems | Oct 2023 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.